[go: up one dir, main page]

MX2019003744A - Interferones de variante tipo iii y sintecinas. - Google Patents

Interferones de variante tipo iii y sintecinas.

Info

Publication number
MX2019003744A
MX2019003744A MX2019003744A MX2019003744A MX2019003744A MX 2019003744 A MX2019003744 A MX 2019003744A MX 2019003744 A MX2019003744 A MX 2019003744A MX 2019003744 A MX2019003744 A MX 2019003744A MX 2019003744 A MX2019003744 A MX 2019003744A
Authority
MX
Mexico
Prior art keywords
type iii
synthekines
variant type
iii interferons
interferons
Prior art date
Application number
MX2019003744A
Other languages
English (en)
Inventor
Luis Mendoza Juan
Christopher Garcia Kenan
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of MX2019003744A publication Critical patent/MX2019003744A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)

Abstract

Se proporcionan composiciones y métodos relacionados con los interferones tipo III.
MX2019003744A 2016-09-30 2017-09-29 Interferones de variante tipo iii y sintecinas. MX2019003744A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662402204P 2016-09-30 2016-09-30
PCT/US2017/054498 WO2018064574A1 (en) 2016-09-30 2017-09-29 Variant type iii interferons and synthekines

Publications (1)

Publication Number Publication Date
MX2019003744A true MX2019003744A (es) 2019-10-30

Family

ID=61760153

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019003744A MX2019003744A (es) 2016-09-30 2017-09-29 Interferones de variante tipo iii y sintecinas.

Country Status (12)

Country Link
US (2) US11198717B2 (es)
EP (1) EP3518958A4 (es)
JP (2) JP2019531729A (es)
KR (1) KR20190062490A (es)
CN (1) CN109982714A (es)
AU (1) AU2017336078B2 (es)
BR (1) BR112019006339A2 (es)
CA (1) CA3038533A1 (es)
IL (1) IL265622A (es)
MX (1) MX2019003744A (es)
WO (1) WO2018064574A1 (es)
ZA (1) ZA201902093B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220241376A1 (en) 2019-07-18 2022-08-04 Enyo Pharma Method for decreasing adverse-effects of interferon
CN111407883B (zh) * 2020-05-26 2024-01-12 南通大学 IFN-λ3在刚地弓形虫感染中的新用途
US12060148B2 (en) 2022-08-16 2024-08-13 Honeywell International Inc. Ground resonance detection and warning system and method
WO2024241086A1 (en) * 2023-05-24 2024-11-28 Ambrx, Inc. Pegylated bovine interferon lambda and methods of use thereof
TW202525325A (zh) * 2023-09-04 2025-07-01 美商艾諾斯生技股份有限公司 具有免疫功能之組成物及胜肽

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2413258C (en) * 2000-06-30 2012-01-03 Zymogenetics, Inc. Interferon-like protein zcyto21
US7038032B2 (en) * 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
WO2003066002A2 (en) * 2002-02-08 2003-08-14 University Of Medicine And Dentistry Of New Jersey IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION
CA2534907C (en) * 2003-08-07 2014-04-29 Zymogenetics, Inc. Homogeneous preparations of il-28 and il-29
US20070020227A1 (en) * 2005-07-20 2007-01-25 Sheppard Paul O Use of truncated cysteine IL28 and IL29 mutants to treat cancers and autoimmune disorders
GB0715383D0 (en) * 2007-08-08 2007-09-19 Asterion Ltd Interferon
US20120308517A1 (en) * 2010-02-09 2012-12-06 Digna Biotech, S.L. Compositions for the treatment of infectious and tumoural diseases
US9738696B2 (en) * 2012-08-09 2017-08-22 The Board Of Trustees Of The Leland Stanford Junior University Superkines and synthekines: repurposed cytokines with new and enhanced signaling activities
WO2015103749A1 (en) * 2014-01-08 2015-07-16 Prosit Sole Biotechnology (Beijing) Co. Ltd Fusion polypeptides and methods of use

Also Published As

Publication number Publication date
US20190225665A1 (en) 2019-07-25
AU2017336078B2 (en) 2022-07-21
JP2022191416A (ja) 2022-12-27
ZA201902093B (en) 2021-08-25
US11198717B2 (en) 2021-12-14
CN109982714A (zh) 2019-07-05
IL265622A (en) 2019-05-30
US20220041675A1 (en) 2022-02-10
AU2017336078A1 (en) 2019-04-18
KR20190062490A (ko) 2019-06-05
CA3038533A1 (en) 2018-04-05
WO2018064574A1 (en) 2018-04-05
BR112019006339A2 (pt) 2019-10-01
EP3518958A4 (en) 2021-03-31
EP3518958A1 (en) 2019-08-07
JP2019531729A (ja) 2019-11-07

Similar Documents

Publication Publication Date Title
MX375352B (es) Reguladores de nrf2.
AU2015287674B2 (en) Topical antiviral compositions and methods of using the same
TW201613966A (en) SynTac polypeptides and uses thereof
PH12016500165A1 (en) Compositions and methods related to isolated endophytes
GEP20217239B (en) Pharmaceutical composition
ZA201803875B (en) Interleukin-15 compositions and uses thereof
GB2564510B (en) Compositions and methods and uses relating thereto
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
GB201706352D0 (en) Methods compositions and uses relating thereto
MX373818B (es) Composiciones de apilimod y métodos para usar las mismas.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
GB201706355D0 (en) Methods compositions and uses relating thereto
MX2021014253A (es) Granos de gluten reducido y composiciones de los mismos.
GEP20217240B (en) Pharmaceutical composition
GB201706356D0 (en) Methods compositions and uses relating thereto
MX2019003744A (es) Interferones de variante tipo iii y sintecinas.
GB201616657D0 (en) Methods, compositions and uses relating thereto
GB201616652D0 (en) Methods, compositions and uses relating thereto
MX379126B (es) Formulación de factor viii.
GB201715785D0 (en) Methods compositions and uses relating thereto
GB2550632B (en) Compositions and uses and methods relating thereto
MY167350A (en) Fat-and-oil composition and chocolate
GB201716599D0 (en) Compositions and methods and uses relating thereto
GB201616674D0 (en) Methods, compositions and uses relating thereto
GB201616660D0 (en) Methods, compositions and uses relating thereto